Scarica l'app Stockscreener
6.17
2.15%
0.13
Dopo l'orario di chiusura:
6.17
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MNKD Giù?
Forum
Previsione
Frazionamento azionario
Mannkind Corp Borsa (MNKD) Ultime notizie
MannKind (NASDAQ:MNKD) Shares Down 3.1%Should You Sell? - MarketBeat
MannKind Co. (NASDAQ:MNKD) Sees Large Drop in Short Interest - MarketBeat
International Assets Investment Management LLC Has $86,000 Position in MannKind Co. (NASDAQ:MNKD) - Defense World
MannKind appoints new EVP as executive plans retirement - Investing.com
MannKind Expands Executive Leadership Team - Yahoo Finance
Here’s Why MannKind Corporation (NASDAQ:MNKD) Is Among the Best Diabetes Stocks to Buy Under $10 - Insider Monkey
10 Best Diabetes Stocks To Buy Under $10 - Insider Monkey
MannKind expecting to ‘practically double in size’ with new hires in Danbury - Westfair Online
MannKind Co. (NASDAQ:MNKD) Receives $8.88 Average PT from Analysts - MarketBeat
MannKind Co. (NASDAQ:MNKD) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World
Geode Capital Management LLC Has $39.88 Million Stock Holdings in MannKind Co. (NASDAQ:MNKD) - Defense World
MannKind Target of Unusually High Options Trading (NASDAQ:MNKD) - Defense World
MannKind (NASDAQ:MNKD) Stock Price Down 3.1%What's Next? - MarketBeat
Barclays PLC Buys 338,121 Shares of MannKind Co. (NASDAQ:MNKD) - Defense World
Barclays PLC Purchases 338,121 Shares of MannKind Co. (NASDAQ:MNKD) - MarketBeat
Exploring 3 High Growth Tech Stocks In The United States - Yahoo Finance
MannKind (NASDAQ:MNKD) Research Coverage Started at Wells Fargo & Company - Defense World
FY2025 EPS Estimates for MannKind Lowered by Leerink Partnrs - MarketBeat
Leerink Partnrs Decreases Earnings Estimates for MannKind - Defense World
Wells Fargo Initiates Coverage of MannKind (MNKD) with Overweight Recommendation - MSN
MannKind stock up 10% amid bullish Wells Fargo note - MSN
MannKind (NASDAQ:MNKD) Coverage Initiated by Analysts at Wells Fargo & Company - MarketBeat
MannKind (NASDAQ:MNKD) pulls back 3.8% this week, but still delivers shareholders fantastic 36% CAGR over 5 years - Yahoo Finance
RBC Capital Upgrades MannKind (MNKD) - MSN
MannKind (NASDAQ:MNKD) Trading Up 5.7%Here's Why - MarketBeat
3 High-Growth Biotech Stocks to Watch - Inkl
MannKind (NASDAQ:MNKD) Upgraded to Outperform at Royal Bank of Canada - MarketBeat
Tyvaso DPI royalties and pipeline potential boost MannKind stock—RBC - Investing.com
Noteworthy Wednesday Option Activity: MNKD, BTU, FSLR - Nasdaq
MannKind (NASDAQ:MNKD) Shares Gap UpShould You Buy? - MarketBeat
MannKind to issue shares in debt exchange deal - Investing.com
MannKind to issue shares in debt exchange deal By Investing.com - Investing.com Canada
MannKind trims debt with $194 million note exchange By Investing.com - Investing.com Canada
MannKind to reduce debt by 84% - MSN
MannKind trims debt with $194 million note exchange - Investing.com
MannKind Slashes Debt by 84% in Major Financial Restructuring, Converts $194M Notes to Equity - StockTitan
HighTower Advisors LLC Buys 107,560 Shares of MannKind Co. (NASDAQ:MNKD) - MarketBeat
MannKind (NASDAQ:MNKD) Stock Price Down 5.4%Here's Why - MarketBeat
MannKind Becomes Oversold (MNKD) - Nasdaq
Wellington Management Group LLP Acquires 85,977 Shares of MannKind Co. (NASDAQ:MNKD) - MarketBeat
MannKind Announces Six-Month Results From Phase 3 INHALE-1 Pediatric Diabetes Trial Utilizing Inhaled Insulin (Afrezza®) - Barchart
Mannkind Corp (MNKD-Q) QuotePress Release - The Globe and Mail
MannKind Announces Six-Month Results From Phase 3 - GlobeNewswire
The Manufacturers Life Insurance Company Grows Stake in MannKind Co. (NASDAQ:MNKD) - Defense World
Cipla’s ‘inhaled insulin’ from US’ MannKind Corp adds a ‘layer of convenience’ for those with diabetes - BusinessLine
CDSCO approves Cipla to distribute, market inhaled insulin in India - Daijiworld.com
CDSCO Approves Afrezza® (insulin human) Inhalation Powder in India - Yahoo Finance
Two Sigma Advisers LP Buys 1,000,600 Shares of MannKind Co. (NASDAQ:MNKD) - MarketBeat
MannKind (NASDAQ:MNKD) Cut to "Hold" at StockNews.com - MarketBeat
MannKind Co. (NASDAQ:MNKD) Stock Holdings Increased by BNP Paribas Financial Markets - MarketBeat
MannKind Co. (NASDAQ:MNKD) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Jacobs Levy Equity Management Inc. Makes New $12.25 Million Investment in MannKind Co. (NASDAQ:MNKD) - MarketBeat
MannKind Co. (NASDAQ:MNKD) Holdings Lifted by Parkman Healthcare Partners LLC - MarketBeat
MannKind (NASDAQ:MNKD) Upgraded by StockNews.com to Buy Rating - MarketBeat
Insider Sell Alert: Steven Binder Sells 67,536 Shares of MannKin - GuruFocus.com
MannKind director Steven Binder sells $465k in stock By Investing.com - Investing.com Nigeria
1.44%
7.27%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):